The SNF2-Family Member Fun30 Promotes Gene Silencing in Heterochromatic Loci by Neves-Costa, Ana et al.
The SNF2-Family Member Fun30 Promotes Gene
Silencing in Heterochromatic Loci
Ana Neves-Costa
.¤a, W. Ryan Will
., Anna T. Vetter
.¤b, J. Ross Miller, Patrick Varga-Weisz*
Chromatin and Gene Expression, Babraham Institute, Cambridge, United Kingdom
Abstract
Chromatin regulates many key processes in the nucleus by controlling access to the underlying DNA. SNF2-like factors are
ATP-driven enzymes that play key roles in the dynamics of chromatin by remodelling nucleosomes and other nucleoprotein
complexes. Even simple eukaryotes such as yeast contain members of several subfamilies of SNF2-like factors. The FUN30/
ETL1 subfamily of SNF2 remodellers is conserved from yeasts to humans, but is poorly characterized. We show that the
deletion of FUN30 leads to sensitivity to the topoisomerase I poison camptothecin and to severe cell cycle progression
defects when the Orc5 subunit is mutated. We demonstrate a role of FUN30 in promoting silencing in the heterochromatin-
like mating type locus HMR, telomeres and the rDNA repeats. Chromatin immunoprecipitation experiments demonstrate
that Fun30 binds at the boundary element of the silent HMR and within the silent HMR. Mapping of nucleosomes in vivo
using micrococcal nuclease demonstrates that deletion of FUN30 leads to changes of the chromatin structure at the
boundary element. A point mutation in the ATP-binding site abrogates the silencing function of Fun30 as well as its toxicity
upon overexpression, indicating that the ATPase activity is essential for these roles of Fun30. We identify by amino acid
sequence analysis a putative CUE motif as a feature of FUN30/ETL1 factors and show that this motif assists Fun30 activity.
Our work suggests that Fun30 is directly involved in silencing by regulating the chromatin structure within or around silent
loci.
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Introduction
Chromatin is a complex superstructure that allows DNA fibres
to be organized in the eukaryotic nucleus. Chromatin not only
compacts DNA but also regulates its accessibility by allowing some
sequences to be more available than others, e.g., to transcription
factors [1]. The basic subunits of chromatin are the nucleosomes,
147 bp of DNA wrapped around eight histone proteins.
Alterations of protein-DNA interactions in the nucleosome can
occur by nucleosome remodelling catalyzed by specialized ATP-
dependent enzymes [2]. Nucleosome remodellers alter chromatin
structure by shifting nucleosomes from one position to another
along the DNA (nucleosome sliding) [2]. In other cases they cause
the disruption of nucleosomes or promote the assembly of new
nucleosomes [2]. Some nucleosome remodelling factors also
catalyze the exchange of histones within the nucleosome, for
example, from a canonical histone to a histone variant [2]. A
conserved ATPase domain is the defining feature of the SNF2
family of remodellers, named after its founding member, the
budding yeast Snf2 transcriptional regulator. The SNF2 family is
divided into subfamilies according to sequence similarities [3].
These include the well-characterized SWI2/SNF2, ISWI, CHD/
Mi-2, SWR1 and INO80 subfamilies that all have been shown to
target the nucleosome. The precise roles and activities of several of
the remaining subfamilies are yet to be explored.
Here we characterize Fun30 from the budding yeast Saccharo-
myces cerevisiae and demonstrate that Fun30 promotes gene silencing
in the silent HMR, telomeres and rDNA repeats. We provide
evidence in support of a direct role of Fun30 in promoting
silencing and show that the ATPase function of Fun30 is essential
for its activity.
Results
Identification of a Novel Sequence Feature of Members
of the FUN30/ETL1 SNF2-Subfamily
Proteins of the SNF2 family are defined by the presence of
specific conserved domains in addition to the ATPase domain,
such as the bromodomain for the SWI2/SNF2 subfamily or the
SANT domain for the ISWI subfamily [2]. A bioinformatics
analysis of SNF2 subfamilies identified the FUN30 subfamily
based on conserved features within the common helicase-like
region [3]. We compared the sequences of SNF2 factors from
budding and fission yeast by bioinformatic analysis, with focus on
the regions outside the ATPase domains. This analysis also
identified Fun30 from budding yeast as a member of a distinct
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fission yeast, mouse ETL1 and human SMARCAD1 [4,5], the
Neurospora crassa factor Crf10-1 (also called CLOCKSWITCH)
[6,7], the Arabidopsis thaliana AT2G02090, the Caenorhabditis elegans
M03C11.8 and the Drosophila melanogaster G5899. To gain more
information about defining protein sequence features of the
FUN30 family, we compared Fun30 with the closely related Fft
factors Fft1, Fft2 and Fft3 and the more distantly related budding
yeast Snf2. The ATPase domain of Fun30 is very similar to the
ATPase domains of the Fft factors in its sequence, and slightly less
to Snf2 ATPase domain (Table 1). Similarly, the N- and C-termini
of Fun30 exhibit a high degree of similarity to those of the Fft
proteins, but less so to those of Snf2 (Table 1). The similarity
between the C-terminal domains of Fun30 and the Fft factors is
due to a predicted Helicase-c domain (Helicase conserved C-
terminal domain), found in all SNF2 factors and in many other
helicase-like proteins (Figure 1A). This domain may not necessarily
mediate DNA unwinding, but may be involved in tracking along
the DNA [8]. In the N-terminal domain of Fun30 we identified a
putative UBA (Ubiquitin Associated domain)-like motif: the CUE
motif (Coupling of Ubiquitin conjugation to ER degradation
(Figure 1A). This motif, known to interact with ubiquitin (reviewed
in [9]), stretches over 35 amino acid residues and is characterized
by a phenylalanine (or leucine)-proline (FP/LP) separated by a
defined number of amino acids from a leucine (L) [10]. The
conserved regions have been shown to be required for ubiquitin
binding and cellular functions, as observed for the prototypical
CUE motif-containing protein in budding yeast, Vps9, involved in
the endocytic pathway [11,12,13,14]. The FUN30/ETL1 CUE
motifs vary in their sequence: for example, the characteristic FP
motif is in some cases replaced by the similarly hydrophobic LP
motif, as described for other CUE motif-containing proteins
(Figure 1B) [10].
We investigated if the CUE domain is a unifying feature of the
FUN30/ETL1 subfamily. Fft1 and Fft3 have a putative CUE
motif in their N-terminal regions, similar to Fun30. In contrast, a
putative CUE motif in Fft2 is located downstream of the ATPase
domain. In the homologous mouse ETL1 and human SMAR-
CAD1 factors we identified putative tandem CUE motifs N-
terminal to the ATPase domain (CUE motif 1 and CUE motif 2,
Figure 1A, B). The CUE motif 1 and CUE motif 2 are identical
between mouse and human (Figure 1B) and separated by around
50 amino acid residues that differ in sequence from mouse to
human (not shown). It is possible that the two CUE motifs in
SMARCAD1/ETL1 function cooperatively, as CUE motifs have
been shown to function as dimeric modules in other proteins
[13,15]. We could not identify potential CUE motifs in the
Arabidopsis thaliana AT2G02090 and the Caenorhabditis elegans
M03C11.8. In conclusion, we found that the putative CUE motif
is conserved in several FUN30/ETL1 factors ranging from yeast
to human.
Deletion of FUN30 Renders Cells Sensitive to
Topoisomerase I Inhibitor Camptothecin
Deletion of FUN30 does not affect cell viability in normal
conditions ([16], Figure 2A). We tested if deletion of FUN30
affected cell growth under various stress conditions, including
environmental stress (elevated temperature, heatshock, formam-
ide, osmotic stress, hydrogen peroxide) and nutritional stress
( c a r b o n - ,n i t r o g e n - ,s u l p h a t e - ,i n o s i t i d e -s t a r v a t i o n ) .W ed i dn o t
find that deletion of FUN30 affected viability in these assays, as
shown for growth under elevated temperature (Figure 2A, data
not shown). This is in contrast to a previous study that indicated
temperature sensitivity of fun30-deleted cells [16]. The discrep-
ancy may be explained by different strain backgrounds used
in this study. Thiabendazole which causes destabilization of
mitotic spindles did not have a significant effect on fun30-deleted
cells (not shown). Two high-throughput screens indicate genetic
interactions between FUN30 and genes involved in protein
transport between the Golgi apparatus and the endoplasmatic
reticulum, ER [17,18]. To further examine this finding, we grew
wildtype and fun30-deleted cells in the presence of brefeldin A,
ad r u gt h a ti n t e r f e r e sw i t hE R - G o l g it r a n s p o r t .H o w e v e r ,w ed i d
not observe a significant difference in viability (not shown).
Mutant cells that are defective in transcription elongation often
show enhanced sensitivity to 6-azauracil, but fun30-deleted
cells did not show this (not shown). The deletion of FUN30 has
been reported to lead to a modest increase in survival after UV
irradiation, suggesting a role in the DNA damage response [19].
However, we did not observe growth differences between control
cells and fun30-deleted cells under several DNA damage-
inducing conditions tested, inclu d i n gg r o w t hi nt h ep r e s e n c eo f
methylmethanosulfonate (MMS, Figure 2B), etoposide, amsa-
crine, zeocin, and hydroxyurea. Interestingly, deletion of FUN30
caused a mild, but reproducible growth defect in the presence
of topoisomerase I inhibitor camptothecin (CPT), especially
when grown at an elevated temperature (Figure 2C, D). CPT
binds topoisomerase I, trapping it as a reaction intermediate
covalently bound to DNA. This is thought to form ‘roadblocks’
for the transcription and DNA replication machineries tracking
along the DNA, leading to DNA double strand breaks if not
resolved.
FUN30 Interacts Genetically with ORC to Promote Cell
Cycle Progression
A previous study used a synthetic lethality screen to discover
genes that genetically interact with temperature sensitive muta-
tions in the ORC2 and ORC5 subunits. This screen identified
FUN30 among several other genes [20]. Because this interaction
was not further characterized, we deleted FUN30 in the orc5-1
mutant background. We observed that the double mutant cells
exhibited poor growth at 23uC, 30uC, and 37uC, whereas orc5-1
single mutants show normal growth at 23uC and 30uC, but not at
37uC and the fun30 mutant cells did not show any remarkable
temperature sensitivity (Figures 2 A, 3 A). Cell cycle analysis by
flow cytometry showed that fun30-deletion mutants do not exhibit
a noticeable defect in cell cycle progression (Figure 3 B, wt,
Table 1. Identity between Fun30 protein sequence and the
sequences of the related Fft proteins and of Snf2.
N- and C-ter ATPase
Fun30 100
* 100
*
Fft1 62.1 51.1
Fft2 45.5 56.6
Fft3 63.9 48.1
Snf2 22.5 37.9
Each protein sequence was compared with Fun30 sequence and the results are
presented in percentage identity. The complete sequences of the proteins were
divided in shorter sequences and analysed separately: N-ter refers to the
sequence from the beginning of the protein until the beginning of the ATPase
domain; ATPase refers to the entire ATPase domain; C-ter refers to the sequence
from the end of the ATPase domain until the end of the protein. The results for
N-ter and C-ter were added and are shown in N- and C-ter column.
doi:10.1371/journal.pone.0008111.t001
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not shown). The orc5-1 mutants exhibited some alteration in the
cell cycle profile as previously reported [21] (Figure 3 B, orc5-1).
However, the orc5-1, fun30D double mutant showed what appears
to be drastic defects in their cell cycle profile, with cells apparently
accumulating in G1-early S phase with under-replicated DNA
(genome content between 1n and 2n) and a substantial number of
cells showing a genome content below 1n (Figure 3 B, orc5-1,
fun30D). However, it is not uncommon that yeast DNA FACS
profiles display artifactual shifts to what appears lower DNA
content. Therefore, this could conceivably mean that the orc5-1;
fun30D double mutants’ FACS profile is the same as wildtype,
indicating that the FUN30 deletion is epistatic to the orc5-1 G2
phenotype. To resolve this issue, we scored bud formation, which
is tightly linked to cell cycle progression in budding yeast and can
be used to monitor defects in the cell cycle. Scoring the number of
cells with a bud showed that the orc5-1, fun30D double mutants
exhibit an almost 2 fold reduction of cells with a bud, indicating a
Figure 1. Fun30, Fft1-3, and SMARCAD1/ETL1 are SNF2-factors characterized by putative CUE motifs. A. Diagrams of Saccharomyces
cerevisiae (Sc) Fun30, Schizosaccharomyces pombe (Sp) Fft1, Fft2, Fft3, Neurospora crassa (Nc) CLOCKSWITCH, Arabidopsis thaliana (At) AT2G02090,
Drosophila melanogaster (Dm) CG5899, Caenorhabditis elegans (Ce) M03C11.8 and Human / mouse (Hs, Mm) SMARCAD1/ETL1 with relative positions
of putative CUE motifs (green), SF2 ATPase (blue) and helicase-c domains (red). The amino acid positions for the SNF2_N domains are indicated. CUE
motifs were not apparent in AT2G02090 and M03C11.8. B. Sequence alignments of the putative CUE motifs of Vps9, Fun30, Fft1-3, CLOCKSWITCH,
CG5899, ETL1 and SMARCAD1. Conserved FP/LP and L positions are indicated by grey boxes.
doi:10.1371/journal.pone.0008111.g001
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not enter S phase (Figure 3 C). In summary, these findings indicate
that ORC and FUN30 interact genetically to promote cell cycle
progression.
Fun30 Is Involved in Silencing at a Heterochromatic
Locus, HMR
Several genes identified in the ORC synthetic lethality screen
have been linked to gene silencing, including ASF1, HST1, HST3,
and SUM1 [20,22,23,24,25,26,27,28,29,30]. Therefore, we tested
if Fun30 is involved in gene silencing at the silent mating-type
locus HMR. This is a well characterized locus where heterochro-
matin-like structures are assembled in budding yeast [31].
Repression of the HMR locus requires several trans-acting factors
and cis-acting sequences called silencers that flank this region
(reviewed in [31]). The HMR-E silencer is necessary and sufficient
for repression and consists of three sites (A, E, and B), which are
partially redundant and bind ORC, Rap1p and Abf1p (reviewed
in [31]). We used a strain with an ADE2 reporter gene insertion in
the silent mating type locus HMR, with the endogeneous ADE2
mutated [32]. Silencing of the ADE2 gene results in red colonies,
whereas a loss of silencing results in white colonies [32]. Silencing
was also examined in strains containing mutations in either the
ORC binding site or the ABF1 binding site of the HMR silencer
(Figure 4A, [32]). Deletion of FUN30 resulted in a loss of silencing
of ADE2 in the HMR, whereas the cells expressing Fun30
maintained silencing when the silencer element was intact
(Figure 4B). The degree of silencing appeared to decrease as
silencer elements were mutated, as indicated by pink rather than
red colonies, but deletion of FUN30 de-repressed ADE2 even
further giving rise to white colonies (Figure 4B). A similar assay
that monitors viability in the absence of adenine confirms that
Fun30 is involved in silencing, because the fun30 mutant cells grow
better in the absence of adenine (Figure 4C). However, in this
assay the deletion of the ORC-binding site, the deletion of FUN30,
or the double mutation result in almost the same growth,
indicating possible epistatic relationship between ORC and
Fun30 at this locus. RT-PCR analysis indicates that Fun30 does
Figure 2. Deletion of FUN30 affects viability on camptothecin containing media. A. Strain Y00000 (wt) and Y00389 (fun30D) were spotted
after ten-fold serial dilution on rich medium agar (YPD) and grown for 2 days at the indicated temperatures. B. Same as in (A) but plates contained the
indicated amounts of methylmethanosulfonate (MMS) and were incubated for 3 days at 30uC. C. Same as in (A) but serial dilution was five-fold on
YPD, 1% DMSO (control) or YPD, 1% DMSO and indicated amounts of camptothecin. Growth was at 30uC. D. Same as in (A) but plates contained
10 mM camptothecin and were incubated 3 days at indicated temperatures.
doi:10.1371/journal.pone.0008111.g002
Silencing Role for Fun30
PLoS ONE | www.plosone.org 4 December 2009 | Volume 4 | Issue 12 | e8111Figure 3. FUN30 interacts genetically with ORC in cell cycle progression. A. FUN30 was deleted in strains JRY7385 (wt) and JRY7459 (orc5-
1)[20]. The deletion and source strains were spotted onto rich medium (YPD) agar plates after a 10-fold serial dilution series and incubated for 2 days
at the indicated temperatures. B. Flow cytometry profiles, measuring DNA content versus cell number, were determined for the strains described
above. 1n and 2n indicates the cellular DNA content, unreplicated and replicated, respectively. C. The budding index of the strains described in A was
determined as the percentage of cells with buds in an exponentially growing cell population in rich medium at 30uC. The results are the average of
three independent cultures for each strain and standard deviation.
doi:10.1371/journal.pone.0008111.g003
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showing that its silencing function is linked to the repressed state of
the HMR locus.
Fun30 Is Involved in Silencing of Reporter Genes at
Telomeres and within the rDNA Repeats
We tested if Fun30 has a general role in promoting silencing
within heterochromatin like regions in yeast, affecting regions
other than the HMR, such as the telomeres and rDNA repeats
[31,33,34]. Reporter assays in fun30-deleted cells containing an
ADE2 reporter gene inserted in telomeric region of the right arm
of chromosome V and an URA3 reporter gene inserted close to
telomere of the left arm of chromosome VII while the
endogeneous genes were inactivated ([35], Figure 5A) showed
that FUN30 is involved in telomeric silencing (Figure 5 B, C).
Figure 4. Fun30 is involved in silencing in the HMR locus. A.
Diagram of the HMR silencing reporter (adapted from [32]). B. Colonies
of the strains YLS410 (wildtype silencer, [32]), YLS404 (DA silencer, [32])
and YLS586 (DB silencer, [32]) turn red because of lack of expression of
ADE2. When FUN30 is deleted in these backgrounds, the colonies stay
white, indicating derepression of ADE2. C. The role of Fun30 in
repressing the ADE2 reporter embedded in the HMR is tested by
monitoring growth in the absence of adenine. The repression of the
ADE2 reporter gene in the ‘wt’ strain (YLS410) leads to reduced growth
compared to the fun30D isogenic strain. 10-fold serial dilutions of cells
were spotted on agar plates with minimal glucose medium (MinGlu) or
minimal glucose medium without adenine (MinGlu-Ade) and incubated
for 3 days at 30uC. D. Fun30 does not regulate ADE2 in its endogeneous
locus. The amount of ADE2 mRNA expressed from its endogenous locus
in control (JS311, [37]) and its fun30-deleted sister strain was
determined after reverse transcription of the mRNA and quantitative
PCR and normalized to ACT1 expression. Shown is the average of two
experiments with standard deviation.
doi:10.1371/journal.pone.0008111.g004
Figure 5. Fun30 is involved in silencing at telomeres and the
rDNA repeats. A. Diagram of the telomeric reporter genes in strain
YTI312 (adapted from [35] oval: centromere, open boxes:URA3 and
ADE2 reporter genes, small ovals: telomere. B. Silencing of the telomeric
ADE2 (YTI312, [35]) in the presence but not in the absence of Fun30
(YTI312;fun30D). C. Analysis of role of Fun30 in telomeric silencing of a
URA3 reporter by serial dilution assay on plates without or with 5-FOA.
D. Representation of the rDNA structure of strain JS306 (adapted from
[37]). E. Analysis of role of Fun30 in silencing of HIS3 or MET15 reporter
genes within the rDNA locus by serial dilution assay on plates with
complete synthetic media or media lacking either histidine or
methionine.
doi:10.1371/journal.pone.0008111.g005
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100-200 repeats of 9.1 kbp units on chromosome XII. Silencing of
Pol II-transcribed reporter genes occurs within the rRNA locus,
even though this region is actively transcribed by Pol I and Pol III
[31,34,36]. We used reporter assays, where the genes HIS3
(conferring auxotrophy in the absence of histidine added to the
media), URA3 (conferring auxotrophy in the absence of uracil or
sensitivity to 5-Fluoroorotic acid, 5-FOA) and MET15 (conferring
auxotrophy in the absence of methionine) have been inserted
within rDNA repeats (with the endogeneous genes inactivated), to
test if Fun30 is involved in silencing there [37] (Figure 5 D).
Deletion of FUN30 significantly improved the growth of the cells in
the absence of histidine or methionine, indicating the Fun30 is
involved in rDNA silencing (Figure 5 E). The effect of deletion of
FUN30 on growth minus uracil or survival in the presence of 5-
FOA was less pronounced (not shown). In summary, our data
support a general role of Fun30 in promoting silencing in budding
yeast.
Fun30 Is Enriched at the HMR Heterochromatin and
Boundary Element and Regulates Chromatin at the HMR
Barrier Element
A san e x ts t e pw ee x a m i n e di fF un30 is directly involved in
silencing by binding within or at silenced loci and mediating
changes of chromatin structure there. We focused this analysis
on the telomere-proximal side of HMR, because it contains a
defined boundary element, a tRNA, which creates a sharp
transition between heterochromatin and euchromatin [38]. We
used chromatin immunoprecipitation to test if Fun30 binds to
the silent HMR, including the boundary region and regions
outside of the heterochromatin. Chromatin immunoprecipita-
tion studies were performed using an affinity-purified polyclonal
antibody generated against Fun30. This antibody is specific for
Fun30, because it did not immunoprecipitate chromatin from a
fun30-deletion strain (Figure 6A). Consistent with a direct role of
Fun30 in determining heterochromatin structure, Fun30
occupancy was increased at the barrier tRNA gene, as well as
further upstream at the silent a1 locus (Figure 6B). Fun30
occupancy was decreased in a region between the tRNA gene
and the GIT1 gene and within the coding region of GIT1
(Figure 6B). This suggests that Fun30 directly associates with the
heterochromatic HMR and the boundary element, influencing
chromatin structure there. We tested Fun30 occupancy at
telomere VIR and found that occupancy, as measured by
immunoprecipitation efficiency compared to input, was overall
significantly lower compared to the HMR locus. However,
within that site, occupancy was highest close to the telomere end
and progressively dropped at loci towards the centromere
(Figure 6C).
Micrococcal nuclease analysis was performed on chromatin of
yeast nuclei to test if Fun30 affects chromatin structure at the
HMR locus. Deletion of FUN30 did not detectably alter global
chromatin structure (Figure 7, left panels). Probing digested
chromatin for the region flanking the HMR boundary revealed an
increase in nuclease sensitivity at the tRNA gene and within the
HMR in fun30-deleted strains compared to the isogenic wildtype
strain, in line with the notion that Fun30 is required to create a
restrictive chromatin structure (Figure 7, right panels).
We used the HMR silencing assay in the presence of
camptothecin to determine whether the fun30 null allele has a
direct effect on silencing or if the silencing phenotypes are caused
indirectly by fun30 through constitutive activation of a pathway(s)
normally induced by the presence of roadblocks such as single
strand nicks with a covalent DNA-protein bond. We found that
camptothecin at levels that inhibited growth of fun30-deleted cells
did not affect the HMR gene silencing in control cells as monitored
by the ADE2 reporter assay (Figure 8). In conclusion, our data
provide evidence for a direct role of Fun30 in silencing at the
HMR.
Figure 6. Fun30 binds at the silent HMR locus. A. Validation of the
specificity of the affinity purified Fun30 antibody for chromatin
immunoprecipitation (ChIP). Control (wt) and fun30D cells were
analyzed by ChIP with Fun30 antibody. Immunoprecipitated DNA was
quantified at the a1 locus using quantitative PCR, corrected for
background signal using the IgG control, and normalized relative to
input. Shown is a representative result of two repeat experiments. B.
upper panel: ChIP analysis of Fun30 occupancy across the HMR barrier.
Error bars are standard deviation of the two biological replicates of this
experiment. Lower panel: Diagram of the HMR barrier region. Arrows
indicate the orientation of specific genes in the region. Small bars
underneath indicate the relative position of qPCR probes used in ChIP
analyses. C. Fun30 occupancy near the telomere VIR.
doi:10.1371/journal.pone.0008111.g006
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Supportive for Activity of Fun30
The ATPase activity of Snf2-like factors is essential for most of
their biological functions, and point mutation of critical residues
involved in ATP binding usually results in the same phenotype as
the full deletion of the gene [39,40,41]. Likewise, the deletion or
mutation of critical domains flanking the ATPase, such as the
bromodomain in SWI/SNF, has been shown to affect the function
of the protein in many instances [42,43,44]. We tested the role of
Fun30’s ATP-binding site and putative CUE motif for silencing in
the HMR. Expression in trans was from a multi-copy plasmid under
the control of the inducible GAL1 promoter. Complementation
with the wildtype Fun30 in the fun30-deleted strain restored the
silencing of the ADE2 reporter embedded in the HMR (Figure 9A).
Complementation with an ATPase binding site point mutant of
the Walker A motif (GKT to GRT) or a negative control vector
did not (Figure 9A). Deletion of the CUE motif in the expression
construct (deletion of aminoacids 73 to 111) resulted in pink and
white colonies, indicating that silencing was not as strong and
stable with this mutant Fun30 (Figure 9A, CUE deletion). The
experiments shown in Figure 9A were performed with cells grown
on galactose for full induction of Fun30 expression. Expression
levels between wildtype, ATPase mutant Fun30 and the CUE
deletion mutant Fun30 were similar in this condition (Figure 9B).
The low-level, uninduced expression of Fun30 also rescued
silencing (not shown). Therefore, Fun30 is involved in silencing
an RNA polymerase II dependent reporter gene when embedded
in a heterochromatin-like locus, the ATPase activity of Fun30 is
essential for its silencing activity and the CUE motif assists in full
silencing.
Overexpression of Fun30 has been shown to result in poor cell
viability, possibly because of chromosome instability [16]. We
tested if the ATPase function and the putative CUE motif are
involved in this phenotype by overexpressing wildtype and mutant
Fun30 using the constructs described above (Figure 9B). When
wildtype Fun30 expression was induced with galactose, cell growth
was severely impaired when compared with cells expressing the
control protein b-galactosidase (Figure 9C). The toxicity of the
protein was dependent on the ATPase activity, as overexpression
of the ATPase point mutant of Fun30 did not affect cell growth,
suggesting that the point mutation in the ATPase mutant impairs
the activity of the protein (Figure 9C). To test the importance of
the CUE motif for the toxicity phenotype, we overexpressed the
CUE-deletion mutant, as well as a version of Fun30 in which the
residues that are critical for ubiquitin binding in other CUE motifs
have been mutated (aminoacids 82 and 83: FP mutated to AA, the
equivalent residues have been shown to bind ubiquitin in the CUE
motifs of other proteins [12,14]). The results show that both the
overexpression of the CUE-deletion and the CUE-point mutant
protein caused diminished growth (Figure 9C). However, the
deleterious effect of over-expression of these mutants was less than
that caused by the full-length protein.
Discussion
We show that Fun30 is required for silencing of reporter genes
embedded within transcriptionally repressed domains, the silent
HMR, telomeres and rDNA repeats. The ATPase function appears
essential for this activity, because mutating an essential lysine
residue in the ATPase domain abrogates this function. A toxicity
assay upon overexpression reinforces the importance of the
ATPase for Fun30 activity. In budding yeast, ATP-dependent
chromatin remodelling factors ISW1 and ISW2 have been linked
to gene silencing within the HMR and rDNA, but not telomeres,
whereas the SWI/SNF complex has been shown to be required for
rDNA and telomeric silencing, but not silencing within the HMR
and HML loci [30,45,46,47]. Therefore, silencing appears to be
the result of the concerted action of several remodelling factors.
Fun30 appears to be special in that it affects silencing in the HMR,
telomeres and rDNA loci. We can presently not exclude an
indirect role of Fun30 in heterochromatin maintenance. However,
we favour a direct role, because we find that Fun30 binds at the
silent HMR locus, and less so to the adjacent euchromatic region.
Furthermore, we find that deletion of Fun30 results in an altered
chromatin structure at the HMR boundary element. Future work
will establish if Fun30 promotes gene silencing in heterochromatin
by assisting the establishment of specific histone modifications
(e.g., histone hypoacetylation), by regulating histone variants, or
heterochromatin-specific non-histone proteins.
Figure 7. Fun30 regulates chromatin structure at the HMR
boundary element Chromatin analysis using micrococcal
nuclease digestion and indirect endlabeling. Spheroplasts were
generated from both a wild-type yeast strain and the isogenic fun30
mutant strain and incubated briefly in the presence of increasing
concentrations of micrococcal nuclease. The purified genomic DNA was
then separated on an agarose gel and analyzed after ethidium bromide
staining (left panels) or by Southern blot analysis for the HMR boundary
region via indirect end-labelling (right panels). Asterisks indicate major
digestion products. The position of the tRNA barrier is indicated by a
small box. The arrow indicates the direction of transcription of the
tRNA. The coding regions for a1 and GIT1 lie upstream and
downstream, respectively, of the analysed fragment. The molecular
size marker (M) is in multiples of 100 bp.
doi:10.1371/journal.pone.0008111.g007
Figure 8. Camptothecin does not abrogate silencing within the
HMR. Silencing reporter strains YLS586 or YLS586; fun30D (see Figure 4)
were grown on minimal glucose medium, 1% DMS0 with or without
30 mM camptothecin (CPT) and the accumulation of red pigment,
indicative of silencing of the ADE2 reporter gene embedded in the HMR,
was monitored as in Figure 4.
doi:10.1371/journal.pone.0008111.g008
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genetic interaction with ORC? Our data suggest that deletion of
the ORC binding site of the silencer element does not completely
abrogate a role of Fun30 in silencing within the HMR. This is
because there is some difference in the accumulation of red
pigment (indicative of silencing) between cells containing single
deletions of either the ORC binding site or FUN30, or the double
mutant in this sensitive assay (see Figure 4B, accumulation of red
pigment is apparent even when growth is not compromised).
However, an assay that monitors growth in the absence of adenine
(and that maybe somewhat less sensitive) indicates at least some
epistatic interaction between the role of Fun30 in HMR silencing
and the ORC binding site within the silencer, because there is
almost no difference in growth between single deletion strains at
the ORC site or FUN30, or the double deletion strains (Figure 4C).
Therefore, there may be an interaction between Fun30 and ORC
at the heterochromatic regions, and this, in turn, may be
important for the silencing-related function of Fun30 and the
replication-related function of ORC at these sites: The ORC
complex may be involved in recruiting Fun30 to establish a silent
chromatin configuration within the HMR or Fun30 may facilitate
the binding of ORC within the silencer element and other sites
within the genome. If the number of functional ORC complexes is
diminished, as in the orc5-1 mutation, the supportive role of Fun30
for ORC establishment may become apparent. Alternatively,
Fun30 may promote cell cycle progression in a parallel pathway to
Figure 9. Role of ATPase function and putative CUE-motif in Fun30 activity. A. Silencing of the ADE2 reporter in YLS586; fun30D is restored
by expressing wildtype Fun30 in trans, but not by a Fun30 ATPase mutant or by a control vector expressing LacZ. Expression of Fun30 with the
putative CUE motif deleted does not restore silencing as monitored by red pigment formation. Expression was in galactose at 30uC, driven by the
galactose-inducible promoter of GAL1. B. Immunoblot analysis of the Fun30 protein in trans-expression with anti-V5 antibody. An immunoblot for
histone H3 served as protein loading control. V5-tagged Fun30 and indicated mutants thereof were expressed in trans in a galactose- or glucose
dependent manner in Fun30 containing strain JRY7385 from multicopy plasmids, the control vector expresses V5-tagged beta-galactosidase. C. Cells
from (B) were serially diluted 10-fold, spotted on media with galactose or with glucose and grown for 3 days at 30uC.
doi:10.1371/journal.pone.0008111.g009
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facilitating DNA polymerase progression through chromatin.
However, it is noteworthy that the deletion of FUN30 does not
affect viability in the presence of hydroxyurea (data not shown), a
drug that inhibits ribonucleotide reductase, leading to diminished
deoxyribonucleotide pools and DNA replication stress. If Fun30
has a role in facilitating replication through chromatin, one would
expect that the deletion of it would aggravate the deleterious effect
of hydroxyurea, as is the case with Ino80, a chromatin remodelling
factor implicated in facilitating chromatin replication [48,49,50].
It is interesting that when other genes involved in silencing are
deleted, they cause synthetic lethality or sickness with ORC
mutants [20]. Additional genes involved in such synthetic
interactions with ORC mutants are involved in cohesion [20].
An interesting suggestion might be that silencing established by
Fun30 and other factors such as ASF1 is linked to some aspect of
cohesin function.
We attempted to obtain further insight into the biological
function of Fun30 by identification of interaction partners using
TAP (Tandem Affinity Purification) of endogenously tagged
Fun30, but did not find any interaction partner using this
approach (data not shown). This may indicate that Fun30 does
not form a heteromeric complex as so many other chromatin
remodelling factors [2]. Another explanation may be that such a
complex is only formed under specific circumstances or is not
extractable from the chromatin under our conditions.
Several members of the FUN30/ETL1 family of remodellers
are characterized by the presence of putative CUE motifs. CUE
motifs of other proteins bind to polyubiquitin chains, but also to
monoubiquitin in vitro [12]. The binding to ubiquitin is required
for the function of CUE motif-containing proteins, for example, in
intracellular trafficking [11,12]. Moreover, the CUE motif can
mediate intramolecular monoubiquitination [9,12,14]. Here, we
provide evidence that the putative CUE motif of the budding yeast
Fun30 is required for the full function of the protein. In chromatin,
regulation by ubiquitin assures genomic stability and cellular
maintenance. Relevant examples of ubiquitinated proteins include
histones [51], PCNA [52], RNA PolII [53], numerous transcrip-
tion factors [54] and various components of the DNA repair
machinery [55]. It will be interesting to determine if the function
of Fun30 is dependent of the recognition of ubiquitinated factors,
e.g., ubiquitinated histones or if Fun30 is regulated by ubiquitin.
However, one cannot presently exclude that CUE motifs and
related motifs recognize other ubiquitin related molecules, such as
SUMO. Future work will determine the mechanisms by which
Fun30 affects gene silencing and if the FUN30/ETL1 putative
chromatin remodellers share biological roles.
Materials and Methods
Sequence Comparisons
We used PFam (http://www.sanger.ac.uk) [56], and SMART
(http://smart.embl-heidelberg.de/) [57] to retrieve the complete
collections of putative SNF2 factors for budding yeast Saccharomyces
cerevisiae and fission yeast Schizosaccharomyces pombe. The length and
sequences of the domains, including the ATPase domains of each
SNF2 factor, were obtained from PFam. In table 1, N- and C-ter
refer to the sequences of the proteins before and after the SNF2_N
domain (see Figure 1 A). Domain assignment for table 1 was as
follows: Saccharomyces cerevisiae (Sc) Snf2 (1703 aa), SNF2_N
domain: from amino acid position 770 to 1065, Helicase-C,
1122-1201; Sc Fun30 (1131 aa), SNF2_N domain: 575-881,
Helicase-C, 985-1063; Schizosaccharomyces pombe (Sp) Fft1 (944 aa),
SNF2_N domain, from 417-699, Helicase-C, 799-877; Sp Fft2
(1284 aa), SNF2_N domain, 553-858, Helicase-C, 959-1037; Sp
Fft3 (922 aa), SNF2_N domain, 390-695, Helicase-C, 796-874.
Sequence similarity searches were performed using the BLASTp
algorithm [58] provided by GeneDB and by SGD, and the PSI-
BLASTp algorithm provided by NCBI [59]. Alignments of protein
sequences were done using the pairwise alignment algorithms
EMBOSS [60], provided by EMBL-EBI (http://www.ebi.ac.uk),
and bl2seq [61], provided by NCBI (http://blast.ncbi.nlm.nih.
gov). Multiple sequence alignments were generated with ClustalW,
available online from EMBL-EBI [62]. For Figure 1B, the
alignment generated by ClustalW was adjusted by hand.
Yeast Culture
Yeast growth and manipulation was according to standard
procedures [63]. The strains used are listed in table 2. Start- to
stop-codon deletion of the Fun30 ORF was by homologous
recombination with the kanMX4 cassette using standard proce-
dures [63]. For viability assays, cultures were grown to saturation.
The cell density was adjusted to 6610
7cells/ ml (OD600=3) with
water, and the cultures were serially diluted by a factor of 10. For
each dilution, 3 ml of cell solution were plated on the appropriate
agar plate and incubated over several days. Silencing assays were
performed as described [32,33,35,37]. For immunodetection, the
antibodies used were Anti-V5 mouse monoclonal (Invitrogen) and
anti-Histone H3 rabbit polyclonal (Abcam). Microscopy was with
an Olympus BX40 microscope, an Olympus objective UplanApo
100x/1.35 oil, an Olympus U-TV 0.5X collector lens and a Soft
Imaging System camera MegaViewII. For the budding index
experiment, three cultures were analysed and at least 200 cells of
each culture were scored. Drugs were tested at following
concentrations: thiabendazole: 75–100 mg/ml, brefeldin A:
500 mg/ml, 6-azauracil: 25–300 mg/ ml, etoposide: 200–
400 mg/ml, amsacrine: 50–100 mg/ml, zeocin: 25–50 mg/ml,
hydroxyurea: 50–300 mM.
Fun30 Expression Plasmids
The coding region of Fun30 excluding the stop codon was
amplified by polymerase chain reaction (PCR) from purified
genomic DNA and cloned into pYES2.1/V5-His-TOPO (Invitro-
gen) to create plasmid PFA1. The ATPase-inactive version of
Fun30 carries a point mutation in the ATPase domain that
replaces lysine at position 603 (AAA) by arginine (AGA) [64]. The
point mutation was introduced with the QuickChange XL Site-
Directed Mutagenesis kit (Stratagene). The template was PFA1
and the primers were: CGACATGGGTCTAGGTAGAACAT-
GTCAAGTCATTTC and GAAATGACTTGACATGTTCT-
ACCTAGACCCATGTCG. Vector PFA5 contains a version of
Fun30 without the CUE motif. From PFA1, a sequence containing
the CUE motif was removed by restriction digestion with the
enzymes Bsu36I and BclI. The resulting fragment was ligated to a
Bsu36I and BclI cleaved DNA fragment amplified from PFA1
using the primers TATATTCCTGAGGATAGGCAGCAA and
GGAAGAACATTTCTTGATCACAGA. PFA12 contains a
version of Fun30 in which phenylalanine at position 82 (TTC)
and proline at position 83 (CCC) have been replaced by alanine
(GCC). The template was PFA1 and the primers were GTTAAC-
CTTGCGAGAGAGGCCGCCGATTTCTCTCAAAC and G-
TTGAGAGAAATCGGCGGCCTCTCTCGCAAGGTTAAC.
Fluorescence-Activated Cell Sorting (FACS)
A culture was grown to early logarithmic phase and up to
8610
6 cells were resuspended in 70% ethanol and incubated at
30uC for 30 min rotating. The cells were washed two times with
PBS buffer (150 mM NaCl; 2.7 mM KCl; 16 mM Na2HPO4;
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staining buffer (BD Biosciences) and incubated at room temper-
ature for 15 min in the dark. The cell suspensions were stored at
4uC and briefly sonicated immediately before use. At least 20000
cells were counted per experiment with a FACSCalibur (BD
Biosciences) flow cytometer and the results were processed with
the CellQuest software.
RT-PCR
RNA isolation was with Fast RNA Pro Red Kit (MP
Biomedicals) after yeast cells were grown to an OD600 of ,0.7.
For RT-PCR, 5 mg RNA was digested with DNAseI, followed by
reverse transcription and quantitative PCR.
Rapid Extraction of Total Protein
Cells of a 5 ml culture grown to saturation were re-suspended in
500 ml of deionized water. 500 ml of 0.3 M of NaOH were added
and the cells were incubated at room temperature for 5 min. After
pelleting, they were resuspended in 100 ml of 0.06 M Tris-HCl
pH 6.8; 5% (v/v) glycerol; 2% (v/v) SDS; 4% (v/v) b-
mercaptoethanol; bromophenol blue and incubated at 95uC for
5 min before immunoblot analysis.
Chromatin Immunoprecipitation (ChIP)
ChIP was performed essentially as described (http://www.
epigenome-noe.net/researchtools/protocol.php?protid=27). Sam-
ples werecrosslinked for15 minwith 1%formaldehyde.Chromatin
samples were sheared to ,500 bp by sonication. All samples were
analyzed by quantitative PCR with a Perkin-Elmer ABI Prism 7700
Sequence Detector System. Oligonucleotides used for the PCR are
listed in table 3. Each ChIP was repeated 2–4 times and normalized
against input. ChIPwas performed using 5 mg of Fun30 antibody or
5 mg of IgG as a control. The rabbitpolyclonal anti-Fun30 antibody
was generated against a recombinant GST-tagged domain (amino
acids 56–136) from Fun30 and affinity purified using a standard
protocol [65].
Miccrococcal Nuclease Digestion
Digestions were performed as described [66], with modifica-
tions. Yeast cultures were grown in 50 ml YPAD to 0.7 OD595,
then pelleted. Spheroplasts were generated by digesting pellets
with 950 ml 2 mg/ml Zymolyase 100T (MP Biomedicals) for 6
minutes. Spheroplasts were then washed as previously described
and digested with 25 or 70 U of micrococcal nuclease for four
minutes. The DNA was purified and digested with EcoRV and
PciI. 3 mg of digested DNA was separated in a 1.7% TBE-agarose
gel and transferred to a nylon membrane. The membrane was
Table 3. Oligonucleotides used in this study.
Primer Sequence (59-39)
a1-F ttggccttatagagtgtggtcgt
a1-R aacattgagaacaagagcaagacg
GIT1d-F gcaccaacaccaatacctacca
GIT1d-R gccactgctatcttggttattgg
HMR-GIT1-F tcaattcttgaatctcaacttccatt
HMR-GIT1-R tccattgatcagtattcatgttcctag
HMR-L probe ggcgatataatttatcatgttttgg
HMR-R probe tgtgcaaattccaactaaagga
TelVIR0.5-F aactgtcggagagttaacaagcg
TelVIR0.5-R tgaactgtgcatccactcgttag
TelVIR4.8-F cttgtcttaggcaggctggagt
TelVIR4.8-R ctgcttcatcatccataaatgatacag
TelVIR9.8-F ttcatggtaattcgtcgagacagt
TelVIR9.8-R atccaattgtcaatgagcaggt
TtRNA-F acactagtaatgtggagatcatcggtt
TtRNA-R agatgacgatggacgcgaac
doi:10.1371/journal.pone.0008111.t003
Table 2. S. cerevisiae strains used in this study.
Strain/ Source Genotype
Y00000 (wt) Euroscarf MATa his3Dl leu2D10 met15Dura3D0
Y00389 (fun30D) Euroscarf MATa his3Dl leu2D10 met15D ura3D0 YAL019w::kanMX4
JRY7385 Suter et al. 2004 [20] MATa his3Dl leu2D10 lys2D ura3D0 can1D mfa1D::MFA1pr-HIS3
JRY7385;fun30D this study MATa his3Dl leu2D10 lys2D ura3D0 can1D mfa1D::MFA1pr-HIS3 YAL019w::kanMX4
JRY7459 Suter et al. 2004 [20] MATa his3Dl leu2D10 lys2D ura3D0 can1D mfa1D::MFA1pr-HIS3 orc5-1::natMX4
JRY7459;fun30D this study MATa his3Dl leu2D10 lys2D ura3D0 can1D mfa1D::MFA1pr-HIS3 orc5-1::natMX4 YAL019w::kanMX4
YLS410 Sussel et al.1993 [32] MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 HMR::2EDA
YLS410;fun30D this study MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 HMR::2EDA YAL019w::kanMX4
YLS404 Sussel et al.1993 [32] MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 GAL
+ hmrDA(D358-352)::ADE2
YLS404;fun30D this study MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 GAL
+ hmrDA(D358-352)::ADE2 YAL019w::kanMX4
YLS586 Sussel et al.1993 [32] MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 GAL
+ hmrDB(D274-256)::ADE2
YLS586;fun30D this study MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 GAL
+ hmrDB(D274-256)::ADE2 YAL019w::kanMX4
YTI312 Iida et al. 2004 [35] MATa bar1D::hisG ade2D::hisG ura3Drvs can1-100 his3-11,15 his4 leu2-3 trp1-1 VIIL-adh4::URA3-TEL VR::ADE2-TEL
YTI312;fun30D This study MATa bar1D::hisG ade2D::hisG ura3Drvs can1-100 his3-11,15 his4 leu2-3 trp1-1 VIIL-adh4::URA3-TEL VR::ADE2-TEL
YAL019w::kanMX4
JS306 (JS311) Smith et al.1999 [34] MATa his3D200 leu 2D1 met15 D0 trp1 D63 ura3-167 RDN1::Ty1-MET15 mURA/HIS3 (JS311 is MATa)
JS306;fun30D This study MATa his3D200 leu 2D1 met15 D0 trp1 D63 ura3-167 RDN1::Ty1-MET15 mURA/HIS32 YAL019w::kanMX4
doi:10.1371/journal.pone.0008111.t002
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random primer labelling from a 151 bp PCR product prepared
using the primers 59-tgtgcaaattccaactaaagga-39 and 59-ggcgataatt-
tatcatgttttcc-39.
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